Interestingly, TGFβ2 is also associated with an increment in glycolysis in glioma and it is released also by several immune cells of the TME as TAMs, particularly those with an M2 profile, and cancer-associated fibroblasts (CAFs) [87,88,89]. This evidence concerns the gene TGFB2 and glioma.